Home / Funds / GSA Capital Partners LLP
GSA Capital Partners LLP
The short positions this fund discloses today, across every market.
25 open positions
6 Markets
November 19, 2026 Last disclosure
213800CWAHHW6YYZII58 LEI
| Issuer | Market | % of capital | Since |
|---|---|---|---|
| Tobii AB | Sweden | 1.20% | October 1, 2026 |
| Valneva SE | France | 1.19% | November 4, 2026 |
| RaySearch Laboratories AB (publ) | Sweden | 1.13% | November 5, 2026 |
| Sivers Semiconductors AB | Sweden | 1.10% | November 19, 2026 |
| Tessellis SPA | Italy | 1.09% | November 10, 2026 |
| Powercell Sweden AB (publ) | Sweden | 1.00% | September 11, 2026 |
| Hilbert Group AB (publ) | Sweden | 0.88% | October 22, 2026 |
| Oncopeptides AB | Sweden | 0.88% | October 19, 2026 |
| Hexagon Composites | Norway | 0.85% | November 6, 2026 |
| Cantargia AB | Sweden | 0.70% | November 9, 2026 |
| DBV Technologies | France | 0.70% | November 17, 2026 |
| EuroAPI | France | 0.70% | October 19, 2026 |
| Hansa Biopharma AB | Sweden | 0.70% | September 28, 2026 |
| Nobia AB | Sweden | 0.70% | November 11, 2026 |
| Smart Eye Aktiebolag (publ) | Sweden | 0.70% | October 19, 2026 |
| OssDsign AB | Sweden | 0.69% | November 11, 2026 |
| Trevi - Finanziaria Industriale SPA | Italy | 0.61% | August 24, 2026 |
| Magnora | Norway | 0.60% | November 19, 2026 |
| Tubacex, S.A. | Spain | 0.59% | November 5, 2026 |
| Intrum AB | Sweden | 0.57% | November 19, 2026 |
| Elliptic Laboratories ASA | Norway | 0.51% | August 26, 2026 |
| Inventiva | France | 0.50% | October 20, 2026 |
| MedinCell | France | 0.50% | October 14, 2026 |
| NSI N.V. | Netherlands | 0.50% | October 6, 2026 |
| Orrön Energy AB | Sweden | 0.50% | November 11, 2026 |
Get the moves on GSA Capital Partners LLP by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Issuer | Market | % of capital | Withdrawn on |
|---|---|---|---|---|
| October 14, 2026 | MedinCell | France | 0.50% | current |
| October 13, 2026 | Oncopeptides AB | Sweden | 1.14% | |
| October 13, 2026 | Pharming Group N.V. | Netherlands | 0.48% | |
| October 12, 2026 | RaySearch Laboratories AB (publ) | Sweden | 0.99% | |
| October 12, 2026 | Solutions 30 SE | France | 0.59% | November 6, 2026 |
| October 12, 2026 | BFF Bank SPA | Italy | 0.46% | |
| October 9, 2026 | RaySearch Laboratories AB (publ) | Sweden | 1.07% | |
| October 9, 2026 | Intrum AB | Sweden | 0.60% | |
| October 9, 2026 | Nobia AB | Sweden | 0.60% | |
| October 7, 2026 | RaySearch Laboratories AB (publ) | Sweden | 1.11% | |
| October 7, 2026 | EuroAPI | France | 0.60% | |
| October 7, 2026 | BFF Bank SPA | Italy | 0.57% | |
| October 7, 2026 | Intrum AB | Sweden | 0.53% | |
| October 6, 2026 | OssDsign AB | Sweden | 0.78% | |
| October 6, 2026 | Solutions 30 SE | France | 0.60% | November 6, 2026 |
| October 6, 2026 | Smart Eye Aktiebolag (publ) | Sweden | 0.60% | |
| October 6, 2026 | NSI N.V. | Netherlands | 0.50% | current |
| October 5, 2026 | Pharming Group N.V. | Netherlands | 0.50% | |
| October 1, 2026 | Tobii AB | Sweden | 1.20% | current |
| October 1, 2026 | BFF Bank SPA | Italy | 0.67% | |
| October 1, 2026 | Pharming Group N.V. | Netherlands | 0.48% | |
| September 30, 2026 | 2020 Bulkers | Norway | 1.80% | October 1, 2026 |
| September 30, 2026 | Solutions 30 SE | France | 0.59% | November 6, 2026 |
| September 30, 2026 | NSI N.V. | Netherlands | 0.48% | |
| September 29, 2026 | 2020 Bulkers | Norway | 1.64% | September 30, 2026 |
| September 29, 2026 | Hilbert Group AB (publ) | Sweden | 1.00% | |
| September 29, 2026 | BFF Bank SPA | Italy | 0.70% | |
| September 28, 2026 | Hansa Biopharma AB | Sweden | 0.70% | current |
| September 25, 2026 | 2020 Bulkers | Norway | 1.43% | September 29, 2026 |
| September 25, 2026 | Oncopeptides AB | Sweden | 1.08% | |
| September 24, 2026 | 2020 Bulkers | Norway | 1.09% | September 25, 2026 |
| September 23, 2026 | 2020 Bulkers | Norway | 0.94% | September 24, 2026 |
| September 23, 2026 | Pharming Group N.V. | Netherlands | 0.50% | |
| September 22, 2026 | Oncopeptides AB | Sweden | 1.19% | |
| September 22, 2026 | 2020 Bulkers | Norway | 0.71% | September 23, 2026 |
| September 22, 2026 | Nyesa Valores Corporacion, S.A. | Spain | 0.48% | |
| September 21, 2026 | Hilbert Group AB (publ) | Sweden | 0.91% | |
| September 18, 2026 | Oncopeptides AB | Sweden | 1.28% | |
| September 18, 2026 | Nyesa Valores Corporacion, S.A. | Spain | 0.59% | |
| September 18, 2026 | NSI N.V. | Netherlands | 0.50% | |
| September 16, 2026 | Hilbert Group AB (publ) | Sweden | 0.81% | |
| September 16, 2026 | Nyesa Valores Corporacion, S.A. | Spain | 0.69% | |
| September 14, 2026 | RaySearch Laboratories AB (publ) | Sweden | 1.00% | |
| September 14, 2026 | Nyesa Valores Corporacion, S.A. | Spain | 0.79% | |
| September 14, 2026 | EuroAPI | France | 0.50% | |
| September 11, 2026 | Powercell Sweden AB (publ) | Sweden | 1.00% | current |
| September 11, 2026 | Solutions 30 SE | France | 0.60% | November 6, 2026 |
| September 11, 2026 | Teixeira Duarte, SA | Portugal | 0.49% | |
| September 10, 2026 | Tobii AB | Sweden | 1.19% | |
| September 9, 2026 | Nyesa Valores Corporacion, S.A. | Spain | 0.89% |
Download 4,324 filings as CSV Columns: Date, Issuer, Market, Disclosed position, Unit, End date. The other formats
The funds short on the same companies
- Citadel Securities (Europe) Limited 5 companies in common
- Arrowstreet Capital, Limited Partnership 4 companies in common
- Connor, Clark & Lunn Investment Management LTD. 3 companies in common
- D E Shaw Co LP 3 companies in common
- Two Sigma Investments, LP 3 companies in common
- Citadel Advisors LLC 2 companies in common
- PDT Partners, LLC 2 companies in common
- Worldquant, LLC 2 companies in common
- AQR Capital Management LLC 1 company in common
- Actus Ray Partners Limited 1 company in common
- ActusRayPartners Limited 1 company in common
- BlackRock Financial Management Inc 1 company in common
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, GSA Capital Partners LLP, data as at November 19, 2026, https://www.quivad.com/detenteur/gsa-capital-partners-llp?page=2